<- Go home

Added to YB: 2019-04-17

Pitch date: 2019-04-17

ICAD:US [bullish]

iCAD, Inc.

-14.57%

current return

Author Info

No bio for this author

Company Info

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy.

Market Cap

$47.6M

Pitch Price

$4.53

Price Target

N/A

Dividend

N/A

EV/EBITDA

-5.90

P/E

-8.21

EV/Sales

1.57

Sector

Health Care Technology

Category

N/A

Show full summary:
ICAD INC COM ICAD:US

A summary for this pitch has not been created yet.

Read full article (0 min)